Hypercalcemia appeared in a patient with glucagonoma treated with octreotide acetate long-acting release.
PABCREATIC neuroendocrine tumours are uncommon neoplasms of the pancreas. They may cause a clinical syndrome due to hormone overproduction. Glucagonoma is a rare kind of pancreatic tumors. Here we report a case of glucagonoma. Hypercalcemia occurred when the patient underwent octreotide acetate long-acting release.
Department of Endocrinology, Key Laboratory of Endocrinology of the Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp&nbsp; Peking Union Medical College, Beijing 100730, China.
Min
M
Rui
Li
L
Li
Mao
M
Jiang-Feng
Gu
G
Feng
Zhu
Z
Hui-Juan
Li
L
Wen-Hui
Li
L
Yu-Xiu
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D005260:Female; D005935:Glucagonoma / Q000188:drug therapy*; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D008875:Middle Aged; D015282:Octreotide / Q000009:adverse effects*; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide